Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus.

doi:10.1590/S1678-9946201759067

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus.

Revista do Instituto de Medicina Tropical de Sao Paulo - 6 Nov 2017

Grando Aline Vitali, Ferreira Paulo Roberto Abrão, Pessôa Mário Guimarães, Mazo Daniel Ferraz de Campos, Brandão-Mello Carlos Eduardo, Reuter Tânia, Martinelli Ana de Lourdes Candolo, Gonzalez Mário Peribanez, Nastri Ana Catharina Seixas-Santos, Campos Aléia Faustina, Lopes Max Igor Banks Ferreira, Brito José David Urbaez, Mendes-Corrêa Maria Cássia

Abstract excerpt

Despite recent advances in therapy for chronic hepatitis C (CHC), the disease caused by genotype 3 virus (GEN3) is still considered a treatment challenge in certain patient subgroups. The aim of this retrospective study was to evaluate the effectiveness and safety of the peginterferon (Peg-IFN) and ribavirin (RBV) combination treatment for GEN3/CHC patients, and to evaluate sustained virological response (SVR)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Polyethylene Glycols

Share to Ribavirin

Share to RNA, Viral

Source

Open in PubMed Open full text

Identifiers

PMID: 29116287
DOI: 10.1590/S1678-9946201759067
PMCID: PMC5679679

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus.PMID 29116287Read ↗

Hepatitis C virus infection: Are there still specific problems with genotype 3?Semantic proximity Read ↗

Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3.Semantic proximity Read ↗

Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents.Semantic proximity Read ↗

Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection.Semantic proximity Read ↗

OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy.Semantic proximity Read ↗

Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic review.Semantic proximity Read ↗

Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3.Semantic proximity Read ↗

Treatment of hepatitis C virus genotype 3-infection.Semantic proximity Read ↗

Genotype 3-hepatitis C virus' last line of defense.Semantic proximity Read ↗

Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study.Semantic proximity Read ↗

Comparison of low-dose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an Indian experience.Semantic proximity Read ↗

The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.